• Yi-Zhi Deng, Ming-Hao Luo, Jing-Chao Luo, Jia-Kun Li, Jia-Qi Chen, Yi-Jie Zhang, Jun-Yi Hou, Ying Su, Guo-Wei Tu, and Zhe Luo.
• Shanghai Medical College, Fudan University, Shanghai, 200032, China.
• BMC Anesthesiol. 2023 May 15; 23 (1): 164164.

BackgroundPatients receiving surgical treatment of acute type A Aortic Dissection (aTAAD) are common to suffer organ dysfunction in the intensive care unit due to overwhelming inflammation. Previous studies have revealed that glucocorticoids may reduce complications in certain patient groups, but evidence between postoperative glucocorticoids administration and improvement in organ dysfunction after aTAAD surgery are lacking.MethodsThis study will be an investigator-initiated, prospective, single-blind, randomized, single-center study. Subjects with confirmed diagnosis of aTAAD undergoing surgical treatment will be enrolled and 1:1 randomly assigned to receive either glucocorticoids or normal treatment. All patients in the glucocorticoids group will be given methylprednisolone intravenously for 3 days after enrollment. The primary endpoint will be the amplitude of variation of Sequential Organ Failure Assessment score on post-operative day 4 compared to baseline.DiscussionThe trial will explore the rationale for postoperative application of glucocorticoids in patients after aTAAD surgery.Trial RegistrationThis study has been registered on ClinicalTrials.gov (NCT04734418).© 2023. The Author(s).

13 keywords...

hide…